Trials / Completed
CompletedNCT01390857
Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 379 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valaciclovir |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Completion
- 2010-05-01
- First posted
- 2011-07-11
- Last updated
- 2017-05-17
- Results posted
- 2011-09-26
Source: ClinicalTrials.gov record NCT01390857. Inclusion in this directory is not an endorsement.